EDWARDS LIFESCIENCES CORP (EWL.DE) Stock Fundamental Analysis
Europe - Frankfurt Stock Exchange - FRA:EWL - US28176E1082 - Common Stock
74.56 EUR
-0.93 (-1.23%)
EWL gets a fundamental rating of 7 out of 10. The analysis compared the fundamentals against 63 industry peers in the Health Care Equipment & Supplies industry. EWL scores excellent points on both the profitability and health parts. This is a solid base for a good stock. EWL is valied quite expensively at the moment, while it does show a decent growth rate. These ratings could make EWL a good candidate for quality investing.
1. Profitability
1.1 Basic Checks
EWL had positive earnings in the past year.
In the past year EWL had a positive cash flow from operations.
In the past 5 years EWL has always been profitable.
Each year in the past 5 years EWL had a positive operating cash flow.
1.2 Ratios
EWL's Return On Assets of 10.31% is amongst the best of the industry. EWL outperforms 87.30% of its industry peers.
The Return On Equity of EWL (13.40%) is better than 73.02% of its industry peers.
The Return On Invested Capital of EWL (9.83%) is better than 76.19% of its industry peers.
EWL had an Average Return On Invested Capital over the past 3 years of 12.44%. This is above the industry average of 9.81%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 10.31% | ||
| ROE | 13.4% | ||
| ROIC | 9.83% |
ROA(3y)21.77%
ROA(5y)18.87%
ROE(3y)29.68%
ROE(5y)26.56%
ROIC(3y)12.44%
ROIC(5y)13.58%
1.3 Margins
The Profit Margin of EWL (23.25%) is better than 90.48% of its industry peers.
In the last couple of years the Profit Margin of EWL has grown nicely.
The Operating Margin of EWL (27.73%) is better than 96.83% of its industry peers.
In the last couple of years the Operating Margin of EWL has remained more or less at the same level.
With an excellent Gross Margin value of 78.19%, EWL belongs to the best of the industry, outperforming 92.06% of the companies in the same industry.
In the last couple of years the Gross Margin of EWL has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 27.73% | ||
| PM (TTM) | 23.25% | ||
| GM | 78.19% |
OM growth 3Y-5.94%
OM growth 5Y-1.04%
PM growth 3Y38.76%
PM growth 5Y26.09%
GM growth 3Y1.43%
GM growth 5Y1.33%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so EWL is still creating some value.
Compared to 1 year ago, EWL has less shares outstanding
EWL has less shares outstanding than it did 5 years ago.
EWL has a better debt/assets ratio than last year.
2.2 Solvency
EWL has an Altman-Z score of 12.64. This indicates that EWL is financially healthy and has little risk of bankruptcy at the moment.
EWL's Altman-Z score of 12.64 is amongst the best of the industry. EWL outperforms 95.24% of its industry peers.
EWL has a debt to FCF ratio of 0.75. This is a very positive value and a sign of high solvency as it would only need 0.75 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 0.75, EWL belongs to the top of the industry, outperforming 93.65% of the companies in the same industry.
EWL has a Debt/Equity ratio of 0.06. This is a healthy value indicating a solid balance between debt and equity.
EWL has a Debt to Equity ratio of 0.06. This is amongst the best in the industry. EWL outperforms 87.30% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.06 | ||
| Debt/FCF | 0.75 | ||
| Altman-Z | 12.64 |
ROIC/WACC1.13
WACC8.69%
2.3 Liquidity
EWL has a Current Ratio of 4.00. This indicates that EWL is financially healthy and has no problem in meeting its short term obligations.
With an excellent Current ratio value of 4.00, EWL belongs to the best of the industry, outperforming 92.06% of the companies in the same industry.
EWL has a Quick Ratio of 3.29. This indicates that EWL is financially healthy and has no problem in meeting its short term obligations.
EWL's Quick ratio of 3.29 is amongst the best of the industry. EWL outperforms 90.48% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 4 | ||
| Quick Ratio | 3.29 |
3. Growth
3.1 Past
The earnings per share for EWL have decreased by -3.75% in the last year.
EWL shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 7.13% yearly.
Looking at the last year, EWL shows a small growth in Revenue. The Revenue has grown by 4.67% in the last year.
The Revenue has been growing slightly by 4.58% on average over the past years.
EPS 1Y (TTM)-3.75%
EPS 3Y5.52%
EPS 5Y7.13%
EPS Q2Q%0%
Revenue 1Y (TTM)4.67%
Revenue growth 3Y1.3%
Revenue growth 5Y4.58%
Sales Q2Q%14.67%
3.2 Future
The Earnings Per Share is expected to grow by 9.50% on average over the next years. This is quite good.
EWL is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 8.55% yearly.
EPS Next Y1.44%
EPS Next 2Y5.94%
EPS Next 3Y7.76%
EPS Next 5Y9.5%
Revenue Next Year4.59%
Revenue Next 2Y7.15%
Revenue Next 3Y8.07%
Revenue Next 5Y8.55%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
EWL is valuated quite expensively with a Price/Earnings ratio of 33.74.
Compared to the rest of the industry, the Price/Earnings ratio of EWL is on the same level as its industry peers.
When comparing the Price/Earnings ratio of EWL to the average of the S&P500 Index (26.34), we can say EWL is valued slightly more expensively.
A Price/Forward Earnings ratio of 29.55 indicates a quite expensive valuation of EWL.
Compared to the rest of the industry, the Price/Forward Earnings ratio of EWL indicates a slightly more expensive valuation: EWL is more expensive than 60.32% of the companies listed in the same industry.
When comparing the Price/Forward Earnings ratio of EWL to the average of the S&P500 Index (23.56), we can say EWL is valued slightly more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 33.74 | ||
| Fwd PE | 29.55 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, EWL is valued a bit more expensive than the industry average as 61.90% of the companies are valued more cheaply.
EWL's Price/Free Cash Flow is on the same level as the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 63.07 | ||
| EV/EBITDA | 25.74 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
EWL has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)23.45
PEG (5Y)4.73
EPS Next 2Y5.94%
EPS Next 3Y7.76%
5. Dividend
5.1 Amount
No dividends for EWL!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
FRA:EWL (12/8/2025, 7:00:00 PM)
74.56
-0.93 (-1.23%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners89.97%
Inst Owner ChangeN/A
Ins Owners0.11%
Ins Owner ChangeN/A
Market Cap43.27B
Revenue(TTM)5.88B
Net Income(TTM)1.37B
Analysts79.05
Price Target81.68 (9.55%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)7.01%
Min EPS beat(2)4.4%
Max EPS beat(2)9.63%
EPS beat(4)4
Avg EPS beat(4)5.38%
Min EPS beat(4)3.4%
Max EPS beat(4)9.63%
EPS beat(8)5
Avg EPS beat(8)2.27%
EPS beat(12)6
Avg EPS beat(12)1.21%
EPS beat(16)7
Avg EPS beat(16)-0.18%
Revenue beat(2)1
Avg Revenue beat(2)0.37%
Min Revenue beat(2)-0.12%
Max Revenue beat(2)0.85%
Revenue beat(4)1
Avg Revenue beat(4)-0.56%
Min Revenue beat(4)-2.1%
Max Revenue beat(4)0.85%
Revenue beat(8)1
Avg Revenue beat(8)-2.7%
Revenue beat(12)2
Avg Revenue beat(12)-2.12%
Revenue beat(16)2
Avg Revenue beat(16)-2.48%
PT rev (1m)6.66%
PT rev (3m)7.11%
EPS NQ rev (1m)0.25%
EPS NQ rev (3m)1.27%
EPS NY rev (1m)1.01%
EPS NY rev (3m)3.38%
Revenue NQ rev (1m)0.06%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0.26%
Revenue NY rev (3m)0.89%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 33.74 | ||
| Fwd PE | 29.55 | ||
| P/S | 8.57 | ||
| P/FCF | 63.07 | ||
| P/OCF | 49.59 | ||
| P/B | 4.94 | ||
| P/tB | 6.9 | ||
| EV/EBITDA | 25.74 |
EPS(TTM)2.21
EY2.96%
EPS(NY)2.52
Fwd EY3.38%
FCF(TTM)1.18
FCFY1.59%
OCF(TTM)1.5
OCFY2.02%
SpS8.7
BVpS15.09
TBVpS10.8
PEG (NY)23.45
PEG (5Y)4.73
Graham Number27.39
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 10.31% | ||
| ROE | 13.4% | ||
| ROCE | 13.97% | ||
| ROIC | 9.83% | ||
| ROICexc | 14.65% | ||
| ROICexgc | 23.24% | ||
| OM | 27.73% | ||
| PM (TTM) | 23.25% | ||
| GM | 78.19% | ||
| FCFM | 13.59% |
ROA(3y)21.77%
ROA(5y)18.87%
ROE(3y)29.68%
ROE(5y)26.56%
ROIC(3y)12.44%
ROIC(5y)13.58%
ROICexc(3y)16.13%
ROICexc(5y)17.4%
ROICexgc(3y)22.87%
ROICexgc(5y)24.4%
ROCE(3y)17.66%
ROCE(5y)19.29%
ROICexgc growth 3Y-5.47%
ROICexgc growth 5Y-8.01%
ROICexc growth 3Y-11.82%
ROICexc growth 5Y-8.6%
OM growth 3Y-5.94%
OM growth 5Y-1.04%
PM growth 3Y38.76%
PM growth 5Y26.09%
GM growth 3Y1.43%
GM growth 5Y1.33%
F-Score6
Asset Turnover0.44
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.06 | ||
| Debt/FCF | 0.75 | ||
| Debt/EBITDA | 0.33 | ||
| Cap/Depr | 138.79% | ||
| Cap/Sales | 3.69% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 56.86% | ||
| Profit Quality | 58.45% | ||
| Current Ratio | 4 | ||
| Quick Ratio | 3.29 | ||
| Altman-Z | 12.64 |
F-Score6
WACC8.69%
ROIC/WACC1.13
Cap/Depr(3y)185.14%
Cap/Depr(5y)236.01%
Cap/Sales(3y)5.48%
Cap/Sales(5y)6.41%
Profit Quality(3y)37.92%
Profit Quality(5y)57.13%
High Growth Momentum
Growth
EPS 1Y (TTM)-3.75%
EPS 3Y5.52%
EPS 5Y7.13%
EPS Q2Q%0%
EPS Next Y1.44%
EPS Next 2Y5.94%
EPS Next 3Y7.76%
EPS Next 5Y9.5%
Revenue 1Y (TTM)4.67%
Revenue growth 3Y1.3%
Revenue growth 5Y4.58%
Sales Q2Q%14.67%
Revenue Next Year4.59%
Revenue Next 2Y7.15%
Revenue Next 3Y8.07%
Revenue Next 5Y8.55%
EBIT growth 1Y4.68%
EBIT growth 3Y-4.72%
EBIT growth 5Y3.49%
EBIT Next Year13%
EBIT Next 3Y12.18%
EBIT Next 5Y12.76%
FCF growth 1Y1.45%
FCF growth 3Y-42.99%
FCF growth 5Y-22.01%
OCF growth 1Y-2.42%
OCF growth 3Y-32.1%
OCF growth 5Y-14.39%
EDWARDS LIFESCIENCES CORP / EWL.DE FAQ
Can you provide the ChartMill fundamental rating for EDWARDS LIFESCIENCES CORP?
ChartMill assigns a fundamental rating of 7 / 10 to EWL.DE.
Can you provide the valuation status for EDWARDS LIFESCIENCES CORP?
ChartMill assigns a valuation rating of 2 / 10 to EDWARDS LIFESCIENCES CORP (EWL.DE). This can be considered as Overvalued.
What is the profitability of EWL stock?
EDWARDS LIFESCIENCES CORP (EWL.DE) has a profitability rating of 8 / 10.
What is the valuation of EDWARDS LIFESCIENCES CORP based on its PE and PB ratios?
The Price/Earnings (PE) ratio for EDWARDS LIFESCIENCES CORP (EWL.DE) is 33.74 and the Price/Book (PB) ratio is 4.94.
How financially healthy is EDWARDS LIFESCIENCES CORP?
The financial health rating of EDWARDS LIFESCIENCES CORP (EWL.DE) is 10 / 10.